State of Alaska Department of Revenue Reduces Position in Henry Schein, Inc. $HSIC

State of Alaska Department of Revenue trimmed its stake in Henry Schein, Inc. (NASDAQ:HSICFree Report) by 6.3% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 13,686 shares of the company’s stock after selling 925 shares during the quarter. State of Alaska Department of Revenue’s holdings in Henry Schein were worth $999,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. JPMorgan Chase & Co. raised its holdings in Henry Schein by 6.5% in the 1st quarter. JPMorgan Chase & Co. now owns 6,373,036 shares of the company’s stock valued at $436,489,000 after acquiring an additional 390,399 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Henry Schein by 4.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,240,933 shares of the company’s stock worth $153,480,000 after buying an additional 103,384 shares during the last quarter. Burgundy Asset Management Ltd. raised its position in shares of Henry Schein by 33.9% in the 1st quarter. Burgundy Asset Management Ltd. now owns 2,235,429 shares of the company’s stock worth $153,105,000 after buying an additional 566,530 shares during the period. Clarkston Capital Partners LLC boosted its holdings in Henry Schein by 0.4% in the first quarter. Clarkston Capital Partners LLC now owns 1,751,570 shares of the company’s stock valued at $119,965,000 after acquiring an additional 7,345 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its stake in Henry Schein by 1.0% during the first quarter. Charles Schwab Investment Management Inc. now owns 1,203,676 shares of the company’s stock worth $82,440,000 after acquiring an additional 11,999 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have weighed in on HSIC. JPMorgan Chase & Co. reduced their price target on shares of Henry Schein from $80.00 to $76.00 and set an “overweight” rating on the stock in a research report on Thursday, August 7th. Robert W. Baird restated a “neutral” rating and set a $72.00 target price (down previously from $82.00) on shares of Henry Schein in a report on Monday, July 14th. Leerink Partners set a $75.00 price target on Henry Schein in a report on Monday, July 14th. UBS Group reduced their price objective on Henry Schein from $75.00 to $70.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 6th. Finally, Evercore ISI upgraded Henry Schein from an “in-line” rating to an “outperform” rating and set a $83.00 target price on the stock in a report on Tuesday, August 26th. Five investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $76.67.

Check Out Our Latest Report on Henry Schein

Henry Schein Stock Performance

Shares of NASDAQ HSIC opened at $67.03 on Monday. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The firm has a market cap of $8.13 billion, a P/E ratio of 21.62, a PEG ratio of 2.21 and a beta of 0.81. The stock has a fifty day moving average price of $67.93 and a two-hundred day moving average price of $68.97. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41.

Henry Schein (NASDAQ:HSICGet Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.09). The firm had revenue of $3.24 billion during the quarter, compared to analyst estimates of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The company’s quarterly revenue was up 3.3% compared to the same quarter last year. During the same quarter last year, the company earned $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Research analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Henry Schein Company Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Read More

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.